KD Pharma Group – Top-Up Single-Asset Fund

capiton has successfully closed a new top-up single-asset fund for its fast-growing portfolio company KD Pharma Group („KD Pharma“). This top-up fund will provide KD Pharma with the equity financing for a number of additional strategic investments, in particular add-on acquisitions as well as organic growth initiatives to transfer KD Pharma‘s unique technology and service portfolio from its core omega-3 market to adjacent market segments, including the medical cannabinoid market and small molecule synthesis.

The transaction was highly oversubscribed by its existing investors, enabling capiton to raise the top-up fund in just three months.

About KD Pharma

KD Pharma is a worldwide leading CDMO and technology leader for the purification of lipids. In particular, KD Pharma focuses on small molecule synthesis and manufacturing highly purified omega-3 fatty acids for pharmaceutical and nutraceutical products.

Since its acquisition in 2013 by capiton IV, a fund managed by capiton, KD Pharma has grown from a single-digit revenue business to one of the industry’s largest players with total sales reaching c. EUR 200m to date. Recent investments include the acquisition of manufacturing assets of Rohner AG as well as manufacturing assets and in-licensing of a novel extraction method from Herbolea Biotech.

In 2019 capiton initiated a GP-led single-asset secondary transaction to provide KD Pharma with the necessary investment horizon and follow-on capital to finance the significant future growth potential expected. Following the successful closing of this GP-led secondary, the company has been held in a single-asset continuation fund structure managed by capiton.

Advisors

capiton was supported in this transaction by CMS Hasche Sigle (asset-level legal advice), POELLATH (fund-level legal advice), EY (tax, structuring) and BMH Bräutigam (notary). The investors were supported by Debevoise & Plimpton (legal advice).

Pressemitteilungen

capiton successfully closes fund VI at €504 million Largest fund in the company’s history Approximately €260 million, including co-investment, already deployed in seven portfolio companies Fund to continue successful deployment in capiton’s focus sectors Pharmaceuticals, Medical Technology, Industrial Technology and Responsible Consumption   Berlin, 24 November 2021 – capiton AG (“capiton”), a leading owner-managed private […]

capiton acquires a stake in Solvis, a sustainable heating pioneer, backing the members of the management team which remain significant shareholders in the company. Solvis is headquartered in Braunschweig, Germany. The company was founded in 1982 and retains its operations in a factory which has been inaugurated as the first zero-emission-facility in Germany in 2002. […]

BIOGGIO, SWITZERLAND – October 4, 2021 – The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a highly-purified form. “Trigal has successfully and profitably grown by being a first mover in the API market for […]

capiton acquires the majority stake in Kutterer Mauer AG, backing one of the founders, Mr. Mauer in continuing the growth story of the company. Mr. Mauer as well as other management members invest alongside capiton. Kutterer Mauer AG is a globally operating manufacturer of caps and closure solutions with >450 employees. The Group designs and […]

We are delighted to announce the successful acquisition of 4PICO Litho by Raith. Raith, the leading global manufacturer of precision technology for nanofabrication instrumentation, has expanded its product offering by adding direct write laser lithography systems – manufactured by 4PICO Litho – to its business strategy. In 2004 4PICO Litho, located near Eindhoven (NL) started […]

capiton acquires majority stake in Stürtz Group. Stürtz Group, headquartered in Neustadt (Wied), Germany, is a market-leading designer, producer, and marketer of automated solutions for the window production industry across the globe. The company generated approximately EUR 46 million in sales in 2020 and employs around 270 FTEs across five locations globally. Stürtz’ product portfolio […]

Dec Group acquires Extract Technology We are delighted to announce the successful acquisition of Extract Technology by Dec Group. Extract Technology is a leading provider of containment and aseptic systems for the pharmaceutical, biotech, nuclear and chemical markets. Extract is headquartered in Huddersfield (UK) with a second facility in New Lisbon (US), serving the fast-growing […]

capiton acquires majority stake in Axxence Group The management team of the Axxence Group acquires in a MBO along with capiton the leading natural aroma chemicals manufacturer from its founder, Joost van Neck. Axxence Group, headquartered in Emmerich, Germany, is a leading manufacturer and supplier of natural aroma chemicals (NACs) for the global flavour & […]

EVP Group acquires Group Korott We are delighted to announce the successful acquisition of Group Korott by EVP Group. Group Korott is a leading manufacturer and distributor of vitamins, minerals, natural cosmetics, as well as sport supplements for the Spanish consumer healthcare market. In addition to its store-brand partnering business, Korott has its own brand […]

Engelmann, with headquarters in Wiesloch, Germany, is the leading European manufacturer of smart heat meters for the sub-metering industry.

Wundex Group, with headquarters in Senden, Germany, is a leading home care provider for patients with chronic wounds. The company‘s qualified wound managers provide home care services that enable faster and more effective wound treatment and significantly reduce the workload of general care providers and physicians, backed by an integrated digital platform.

The company Cedes AG (‚Cedes‘), headquartered in Landquart, Switzerland, is a leading sensor technology company in the elevator and access solutions industry. The company’s products, which utilize infrared and image processing technology, provide solutions for the automation of elevators, escalators, and entrances. Cedes generated approximately CHF 55 million in sales in 2019 with 320 employees. […]